ADVANCED SOLID MALIGNANCIES
Clinical trials for ADVANCED SOLID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED SOLID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental mitochondrial vaccine targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new type of vaccine made from engineered mitochondria (the cell's powerhouses) that carry a tumor-specific antigen. It is for people with advanced solid tumors like lung or colorectal cancer who have no other good treatment options. The main goal is…
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
New hope for advanced cancers: experimental drug AZD9574 enters human trials
Disease control Recruiting nowThis study is testing an experimental drug called AZD9574, given alone or with other cancer treatments, in people with advanced solid tumors that have come back or gotten worse. The main goals are to check the drug's safety and find the right dose. About 695 participants will tak…
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for advanced cancer? early trial of BC2027 begins
Disease control Recruiting nowThis early-phase study tests a new drug called BC2027 in about 180 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants will receive the …
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for advanced cancers: experimental drug BMS-986523 enters human trials
Disease control Recruiting nowThis study is testing a new experimental drug called BMS-986523, given alone or with other cancer medicines, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and find the right dose. About 252 adult…
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 22, 2026 13:50 UTC